Orgenesis Inc. Files 8-K: Director/Officer Changes & Financials
Ticker: ORGS · Form: 8-K · Filed: Nov 1, 2024 · CIK: 1460602
| Field | Detail |
|---|---|
| Company | Orgenesis INC. (ORGS) |
| Form Type | 8-K |
| Filed Date | Nov 1, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $30,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting, officer-changes
TL;DR
Orgenesis Inc. 8-K: Leadership shakeup and financial updates filed Oct 28.
AI Summary
Orgenesis Inc. filed an 8-K on October 28, 2024, reporting changes in its board of directors and certain officers, as well as compensatory arrangements. The filing also includes financial statements and exhibits, indicating ongoing operational and financial disclosures for the company.
Why It Matters
This filing provides insight into the company's leadership structure and financial reporting, which are crucial for investors assessing its stability and future prospects.
Risk Assessment
Risk Level: medium — Changes in directors and officers, coupled with financial statement disclosures, can signal shifts in company strategy or performance that warrant investor attention.
Key Players & Entities
- Orgenesis Inc. (company) — Registrant
- October 28, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 20271 Goldenrod Lane, Germantown, MD 20876 (address) — Principal executive office address
FAQ
What specific changes were made to Orgenesis Inc.'s board of directors or officers?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific details of these changes are not provided in the excerpt.
What type of compensatory arrangements are being disclosed?
The filing mentions 'Compensatory Arrangements of Certain Officers,' but the specific details of these arrangements are not elaborated upon in the provided text.
What is the significance of the 'Financial Statements and Exhibits' being filed?
This indicates that Orgenesis Inc. is providing updated financial information and supporting documents as required by the SEC, which is important for investors to review.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on October 28, 2024.
What is Orgenesis Inc.'s state of incorporation and principal executive office address?
Orgenesis Inc. is incorporated in Nevada and its principal executive office is located at 20271 Goldenrod Lane, Germantown, MD 20876.
Filing Stats: 939 words · 4 min read · ~3 pages · Grade level 12.3 · Accepted 2024-11-01 16:05:16
Key Financial Figures
- $30,000 — d to receive an annual cash retainer of $30,000 and an annual grant of a stock option t
Filing Documents
- form8-k.htm (8-K) — 40KB
- 0001493152-24-043318.txt ( ) — 209KB
- orgs-20241028.xsd (EX-101.SCH) — 3KB
- orgs-20241028_lab.xml (EX-101.LAB) — 33KB
- orgs-20241028_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: November 1, 2024 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary